Examining the role of cannabinoids on osteoporosis: a review
- PMID: 36401719
- DOI: 10.1007/s11657-022-01190-x
Examining the role of cannabinoids on osteoporosis: a review
Abstract
Purpose: Prior research studies have shown that the endocannabinoid system, influenced by CBD and THC, plays a role in bone remodeling. As both the research on cannabis and use of cannabis continue to grow, novel medicinal uses of both its constituents as well as the whole plant are being discovered. This review examines the role of cannabinoids on osteoporosis, more specifically, the endocannabinoid system and its role in bone remodeling and the involvement of the cannabinoid receptors 1 and 2 in bone health, as well as the effects of Δ9-tetrahydrocannabinol (THC), cannabidiol (CBD), and synthetic cannabinoids on bone.
Methods: A comprehensive literature search of online databases including PUBMED was utilized.
Results: A total of 29 studies investigating the effects of cannabis and/or its constituents as well as the activation or inactivation of cannabinoid receptors 1 and 2 were included and discussed.
Conclusion: While many of the mechanisms are still not yet fully understood, both preclinical and clinical studies show that the effects of cannabis mediated through the endocannabinoid system may prove to be an effective treatment option for individuals with osteoporosis.
Keywords: Bone; Cannabidiol (CBD); Cannabinoids; Cannabis; Osteoporosis; Δ9-Tetrahydrocannabinol (THC).
© 2022. International Osteoporosis Foundation and Bone Health and Osteoporosis Foundation.
Similar articles
-
Neuromolecular Mechanisms of Cannabis Action.Adv Exp Med Biol. 2021;1264:15-28. doi: 10.1007/978-3-030-57369-0_2. Adv Exp Med Biol. 2021. PMID: 33332001 Review.
-
Cannabinoids: Therapeutic Use in Clinical Practice.Int J Mol Sci. 2022 Mar 19;23(6):3344. doi: 10.3390/ijms23063344. Int J Mol Sci. 2022. PMID: 35328765 Free PMC article. Review.
-
Molecular Mechanism and Cannabinoid Pharmacology.Handb Exp Pharmacol. 2020;258:323-353. doi: 10.1007/164_2019_298. Handb Exp Pharmacol. 2020. PMID: 32236882 Free PMC article.
-
Cannabis: Drug of Abuse and Therapeutic Agent, Two Sides of the Same Coin.Rev Invest Clin. 2023;75(3):105-128. doi: 10.24875/RIC.23000112. Rev Invest Clin. 2023. PMID: 37441766 Review.
-
Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals.Pharmacology. 2022;107(3-4):131-149. doi: 10.1159/000521683. Epub 2022 Jan 28. Pharmacology. 2022. PMID: 35093949 Review.
Cited by
-
Vaporized Delta-9-tetrahydrocannabinol Inhalation in Female Sprague Dawley Rats: A Pharmacokinetic and Behavioral Assessment.Curr Pharm Des. 2023;29(27):2149-2160. doi: 10.2174/1381612829666230419093809. Curr Pharm Des. 2023. PMID: 37114788 Free PMC article.
-
Fatty acid binding protein 7 plays an important modulatory sex-dependent role on brain endocannabinoid levels and THC metabolism.PLoS One. 2024 Dec 2;19(12):e0313091. doi: 10.1371/journal.pone.0313091. eCollection 2024. PLoS One. 2024. PMID: 39621669 Free PMC article.
-
Trans-ancestry epigenome-wide association meta-analysis of DNA methylation with lifetime cannabis use.Mol Psychiatry. 2024 Jan;29(1):124-133. doi: 10.1038/s41380-023-02310-w. Epub 2023 Nov 7. Mol Psychiatry. 2024. PMID: 37935791 Free PMC article.
-
New Emerging Aspect of Herbal Extracts for the Treatment of Osteoporosis: Overview.Curr Rheumatol Rev. 2024;20(4):361-372. doi: 10.2174/0115733971273691231121131455. Curr Rheumatol Rev. 2024. PMID: 38173067 Review.
-
Shared genetic architecture highlights the bidirectional association between major depressive disorder and fracture risk.Gen Psychiatr. 2024 May 8;37(3):e101418. doi: 10.1136/gpsych-2023-101418. eCollection 2024. Gen Psychiatr. 2024. PMID: 38737893 Free PMC article.
References
-
- Chayasirisobhon S (2019) Cannabis and neuropsychiatric disorders: an updated review. Acta Neurol Taiwan 28(2):27–39
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials